65 related articles for article (PubMed ID: 8855388)
21. Detection of nuclear matrix proteins in serum from cancer patients.
Miller TE; Beausang LA; Winchell LF; Lidgard GP
Cancer Res; 1992 Jan; 52(2):422-7. PubMed ID: 1728414
[TBL] [Abstract][Full Text] [Related]
22. Bladder cancer-associated nuclear matrix proteins.
Getzenberg RH; Konety BR; Oeler TA; Quigley MM; Hakam A; Becich MJ; Bahnson RR
Cancer Res; 1996 Apr; 56(7):1690-4. PubMed ID: 8603421
[TBL] [Abstract][Full Text] [Related]
23. Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases.
Hasholzner U; Stieber P; Zimmermann A; Burges A; Hofmann K; Schmitt UM; Schmeller N; Schalhorn A
Anticancer Res; 1999; 19(4A):2415-20. PubMed ID: 10470168
[TBL] [Abstract][Full Text] [Related]
24. Utilization of nuclear matrix proteins for cancer diagnosis.
Keesee SK; Briggman JV; Thill G; Wu YJ
Crit Rev Eukaryot Gene Expr; 1996; 6(2-3):189-214. PubMed ID: 8855388
[TBL] [Abstract][Full Text] [Related]
25. The utilization of nuclear matrix proteins for cancer diagnosis.
Replogle-Schwab R; Pienta KJ; Getzenberg RH
Crit Rev Eukaryot Gene Expr; 1996; 6(2-3):103-13. PubMed ID: 8855384
[TBL] [Abstract][Full Text] [Related]
26. Nuclear structural proteins as biomarkers of cancer.
Konety BR; Getzenberg RH
J Cell Biochem; 1999; Suppl 32-33():183-91. PubMed ID: 10629118
[TBL] [Abstract][Full Text] [Related]
27. Use of urine-based markers for detection and monitoring of bladder cancer.
Pirtskalaishvili G; Getzenberg RH; Konety BR
Tech Urol; 1999 Dec; 5(4):179-84. PubMed ID: 10591254
[TBL] [Abstract][Full Text] [Related]
28. Nuclear matrix proteins as biomarkers in prostate cancer.
Leman ES; Getzenberg RH
J Cell Biochem; 2002; 86(2):213-23. PubMed ID: 12111991
[TBL] [Abstract][Full Text] [Related]
29. [NMP (nuclear matrix protein)].
Nakai K; Miura Y; Nakai K
Nihon Rinsho; 2005 Aug; 63 Suppl 8():812-4. PubMed ID: 16149648
[No Abstract] [Full Text] [Related]
30. Contemporary non-imaging methods in diagnosis of bladder cancer: a review.
De Graeve N; D'Hallewin MA; Baert L
Acta Urol Belg; 1997 Mar; 65(1):55-8. PubMed ID: 9175284
[TBL] [Abstract][Full Text] [Related]
31. Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer.
Gorin MA; Verdone JE; van der Toom E; Bivalacqua TJ; Allaf ME; Pienta KJ
Nat Rev Urol; 2017 Feb; 14(2):90-97. PubMed ID: 27872478
[TBL] [Abstract][Full Text] [Related]
32. [Significance of current bio- and molecular-markers in urological cancers].
Shimazui T; Akaza H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1008-14. PubMed ID: 15272577
[TBL] [Abstract][Full Text] [Related]
33. Nuclear dreams: the malignant alteration of nuclear architecture.
Nickerson JA
J Cell Biochem; 1998 Aug; 70(2):172-80. PubMed ID: 9671223
[TBL] [Abstract][Full Text] [Related]
34. Prostate-specific membrane antigen: current and future utility.
Gregorakis AK; Holmes EH; Murphy GP
Semin Urol Oncol; 1998 Feb; 16(1):2-12. PubMed ID: 9508077
[TBL] [Abstract][Full Text] [Related]
35. Lucy Wortham James Basic Research Award. Markers of prostatic carcinoma.
Murphy GP
Arch Surg; 1991 Nov; 126(11):1404-7. PubMed ID: 1720951
[TBL] [Abstract][Full Text] [Related]
36. Urinary markers of bladder carcinoma.
Dey P
Clin Chim Acta; 2004 Feb; 340(1-2):57-65. PubMed ID: 14734196
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
